Updated: January 23, 2026
Hycamtin Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Hycamtin (topotecan) can cause serious side effects including severe neutropenia. Learn what to expect, which side effects are dangerous, and when to call your doctor.
Hycamtin (topotecan) is a powerful chemotherapy drug that works by disrupting cancer cell DNA. Like all chemotherapy agents, it affects both cancer cells and some healthy cells, leading to a range of side effects. Understanding what to expect — and knowing which symptoms require immediate medical attention — is essential for staying safe during treatment. This guide explains Hycamtin's most important side effects in plain language.
The Boxed Warning: Severe Myelosuppression
Hycamtin carries the FDA's most serious warning — a
boxed warning — for severe myelosuppression. Myelosuppression means bone marrow suppression: the drug reduces your body's ability to make blood cells. This affects white blood cells (neutrophils), red blood cells, and platelets. In clinical trials:
Grade 4 neutropenia (dangerously low white blood cell count) occurred in 78% of patients receiving IV Hycamtin
Grade 3 or 4 anemia (low red blood cells) occurred in 37% of patients
Grade 4 thrombocytopenia (dangerously low platelets) occurred in 27% of patients
Febrile neutropenia (fever + low white cells, a dangerous combination) occurred in 5% of patients
Sepsis (life-threatening blood infection) occurred in 4% of patients and was fatal in 1%
Because of this risk, your doctor will order frequent blood tests (CBC) throughout your treatment. You must not start your first cycle unless your neutrophil count is at least 1,500/mm³ and your platelet count is at least 100,000/mm³. Subsequent cycles are also held if counts are too low.
Common Side Effects of Hycamtin
The most common non-blood side effects seen with Hycamtin include:
Nausea — very common; anti-nausea medications are usually prescribed
Vomiting — often accompanies nausea; keep hydrated and notify your team if severe
Fatigue and weakness (asthenia) — very common; may worsen with low hemoglobin
Diarrhea — more common with oral Hycamtin capsules; requires aggressive management per your oncologist's protocol
Alopecia (hair loss) — typically reversible after treatment ends
Headache — reported in some patients
Dyspnea (shortness of breath) — can be related to anemia or, rarely, a more serious lung problem (see below)
Serious Side Effects: When to Go to the ER or Call Your Doctor Immediately
Some side effects are medical emergencies. Do not wait — call your oncology team or go to the emergency room immediately if you experience:
Fever (any temperature ≥100.4°F/38°C) — fever during chemotherapy may be the only sign of a serious infection and must be evaluated immediately
Chills, severe shaking, rapid heart rate — possible signs of sepsis
Unusual bruising or bleeding that doesn't stop — sign of low platelets (thrombocytopenia)
Blood in urine, stool, or vomit — serious bleeding signs
Severe abdominal pain with fever and neutropenia — may indicate neutropenic enterocolitis (typhlitis), which can be life-threatening
New or worsening dry cough, chest pain, or shortness of breath — may indicate interstitial lung disease (ILD), which requires immediate discontinuation of Hycamtin
Severe skin irritation, pain, or redness at IV infusion site — sign of IV extravasation (drug leaking outside the vein), which requires immediate management
Reproductive and Pregnancy Considerations
Hycamtin is in Pregnancy Category D — it causes fetal harm. Women of reproductive age must use effective contraception during treatment and for 6 months after the last dose. Men with female partners who can become pregnant should use contraception during treatment and for 3 months after the last dose. Topotecan may also affect fertility. If fertility preservation is a concern, discuss options like egg or sperm banking with your oncologist before starting treatment.
Tips for Managing Side Effects
Take anti-nausea medications as prescribed — don't wait until you feel sick
Stay hydrated, especially if you have diarrhea or vomiting
Avoid activities that require alertness if fatigue is severe
Keep all scheduled blood count appointments — never skip a CBC check
Wash hands frequently and avoid sick contacts — your immune system is compromised
For information on what medications to avoid while taking Hycamtin, see our guide on Hycamtin Drug Interactions.
If you are struggling to find your Hycamtin prescription, read our guide on how to find Hycamtin in stock near you.
Frequently Asked Questions
The most common side effects of Hycamtin (topotecan) are severe myelosuppression (low blood counts), nausea, vomiting, fatigue, diarrhea, alopecia (hair loss), and headache. Grade 4 neutropenia (very low white blood cells) occurs in about 78% of patients receiving IV Hycamtin. Your doctor will monitor your blood counts throughout treatment.
Go to the emergency room or call your oncology team immediately if you develop a fever of 100.4°F (38°C) or higher, signs of bleeding (unusual bruising, blood in urine or stool), severe abdominal pain with neutropenia, or new shortness of breath or chest pain. Fever during chemotherapy can be the only sign of a life-threatening infection.
Yes, alopecia (hair loss) is a reported side effect of Hycamtin. It typically occurs during treatment and is usually reversible after treatment ends. The timing and degree of hair loss vary among patients. Discuss this with your oncologist and consider speaking with a patient navigator or support group if this is a concern.
Neutropenic enterocolitis (also called typhlitis) is a potentially life-threatening inflammation of the intestinal wall that can occur in patients with severe neutropenia. Hycamtin can cause this condition. If you experience fever, neutropenia, and abdominal pain together, seek emergency medical care immediately.
Yes, Hycamtin can cause interstitial lung disease (ILD), which can be fatal. Warning signs include new or worsening dry cough, chest pain, and shortness of breath. If ILD is confirmed, Hycamtin must be permanently discontinued. Risk factors include a history of ILD, pulmonary fibrosis, lung cancer, thoracic radiation, and use of colony-stimulating factors.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Hycamtin also looked for:
More about Hycamtin
30,552 have already found their meds with Medfinder.
Start your search today.





